Abbott Laboratories (ABT) News Today $135.41 -1.04 (-0.76%) Closing price 06/13/2025 03:59 PM EasternExtended Trading$136.15 +0.74 (+0.54%) As of 04:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is Abbott Laboratories Down Today?Abbott Laboratories (NYSE:ABT) shares are trading higher today following several dividend announcements and analyst updates that reinforce the stock’s income appeal and technical strength. Declared its 406th consecutive quarterly dividend of $0.59 per share (annualized yield 1.73%), payable August 15 to shareholders of record July 15 Ranked as one of the “Dividend Kings” delivering up to 34% total returns this year, underscoring its long-term income growth track record Received a consensus “Moderate Buy” recommendation from 19 analysts (14 buy ratings, 4 holds) Relative Strength (RS) rating climbed to 82, signaling strong technical momentum Posted 1+ days agoAI Generated. May Contain Errors. ABT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Trust Point Inc. Has $2.94 Million Position in Abbott Laboratories (NYSE:ABT)Trust Point Inc. lowered its position in Abbott Laboratories (NYSE:ABT - Free Report) by 8.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 22,173 shares of the healthcare product maker's stock after selling 1,995 shares during the period. TrustJune 16 at 6:20 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) is Cyndeo Wealth Partners LLC's 8th Largest PositionCyndeo Wealth Partners LLC decreased its position in Abbott Laboratories (NYSE:ABT - Free Report) by 1.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 176,726 shares of the healthcare product maker's stock after selling 2,213 shares duringJune 16 at 6:20 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Bought by Hanson & Doremus Investment ManagementHanson & Doremus Investment Management raised its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 97.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 25,398 shares of the healthcare product maker's stockJune 16 at 6:19 AM | marketbeat.comBank Pictet & Cie Europe AG Sells 44,492 Shares of Abbott Laboratories (NYSE:ABT)Bank Pictet & Cie Europe AG lessened its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 29.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 108,227 shares of the healthcare product maker's stockJune 16 at 5:31 AM | marketbeat.comBrokerages Set Abbott Laboratories (NYSE:ABT) Price Target at $142.59June 16 at 2:53 AM | americanbankingnews.comJim Cramer Calls Abbott “Really Excellent”June 15 at 5:22 PM | insidermonkey.comAbbott Laboratories (NYSE:ABT) Shares Sold by Mn Services Vermogensbeheer B.V.Mn Services Vermogensbeheer B.V. lowered its position in Abbott Laboratories (NYSE:ABT - Free Report) by 6.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 639,000 shares of the healthcare product maker's stock after sellJune 15 at 9:03 AM | marketbeat.comFairvoy Private Wealth LLC Has $3.78 Million Holdings in Abbott Laboratories (NYSE:ABT)Fairvoy Private Wealth LLC lessened its position in Abbott Laboratories (NYSE:ABT - Free Report) by 7.3% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 28,475 shares of the healthcare product maker's stock after selling 2,250 shares during the period. AbbJune 15 at 8:53 AM | marketbeat.comBrighton Jones LLC Has $7.57 Million Stake in Abbott Laboratories (NYSE:ABT)Brighton Jones LLC lifted its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 10.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 57,040 shares of the healthcare product makeJune 15 at 8:00 AM | marketbeat.comExchange Traded Concepts LLC Buys 90,432 Shares of Abbott Laboratories (NYSE:ABT)Exchange Traded Concepts LLC lifted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 643.6% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 104,482 shares of the healthcare product maker's stock after acquiring an additional 90,43June 15 at 7:59 AM | marketbeat.comRitholtz Wealth Management Has $6.41 Million Stock Position in Abbott Laboratories (NYSE:ABT)Ritholtz Wealth Management increased its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 8.8% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 48,332 shares of the healthcare product maker's sJune 15 at 6:57 AM | marketbeat.comHennessy Advisors Inc. Invests $6.39 Million in Abbott Laboratories (NYSE:ABT)Hennessy Advisors Inc. bought a new position in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 48,200 shares of the healthcare product maker's stock, valJune 15 at 5:27 AM | marketbeat.comCampbell Newman Asset Management Inc. Boosts Stock Holdings in Abbott Laboratories (NYSE:ABT)Campbell Newman Asset Management Inc. increased its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 99.0% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 241,828 shares of the healthcaJune 14 at 7:33 AM | marketbeat.comFarmers & Merchants Investments Inc. Lowers Holdings in Abbott Laboratories (NYSE:ABT)Farmers & Merchants Investments Inc. trimmed its position in Abbott Laboratories (NYSE:ABT - Free Report) by 1.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 179,412 shares of the healthcare produJune 14 at 7:25 AM | marketbeat.comStock Yards Bank & Trust Co. Sells 5,247 Shares of Abbott Laboratories (NYSE:ABT)Stock Yards Bank & Trust Co. cut its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 1.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 313,157 shares of the healtJune 14 at 7:15 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Griffin Asset Management Inc.Griffin Asset Management Inc. trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 7.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 59,940 shares of the healthcare product maker's stock after selling 4,997 shares dJune 14 at 6:53 AM | marketbeat.comBNC Wealth Management LLC Invests $3.12 Million in Abbott Laboratories (NYSE:ABT)BNC Wealth Management LLC acquired a new stake in Abbott Laboratories (NYSE:ABT - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 23,501 shares of the healthcare product maker's stock, valued at approximatJune 14 at 6:53 AM | marketbeat.comGoldstone Financial Group LLC Has $1.84 Million Stock Holdings in Abbott Laboratories (NYSE:ABT)Goldstone Financial Group LLC increased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 39.8% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,901 shares of the healthcare product maker'sJune 14 at 6:35 AM | marketbeat.comIpswich Investment Management Co. Inc. Has $2.13 Million Stake in Abbott Laboratories (NYSE:ABT)Ipswich Investment Management Co. Inc. trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 11.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,046 shares of the healthcare product maJune 14 at 6:19 AM | marketbeat.comElevation Point Wealth Partners LLC Trims Position in Abbott Laboratories (NYSE:ABT)Elevation Point Wealth Partners LLC decreased its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 9.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,511 shares of the healthcare product maJune 14 at 5:53 AM | marketbeat.comWest Branch Capital LLC Has $2.35 Million Stock Position in Abbott Laboratories (NYSE:ABT)West Branch Capital LLC grew its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 13.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,677 shares of the healthcare product maker's stock aftJune 14 at 5:45 AM | marketbeat.comFort Washington Investment Advisors Inc. OH Sells 4,025 Shares of Abbott Laboratories (NYSE:ABT)Fort Washington Investment Advisors Inc. OH lessened its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 11.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 31,711 shares of the healthcare product maker's stock aftJune 14 at 4:57 AM | marketbeat.comAbbott Laboratories Plans Quarterly Dividend of $0.59 (NYSE:ABT)Abbott Laboratories (NYSE:ABT) announced a quarterly dividend on Friday, June 13th. Stockholders of record on Tuesday, July 15th will be paid a dividend of 0.59 per share by the healthcare product maker on Friday, August 15th. This represents a $2.36 annualized dividend and a dividend yield of 1.73%.June 13 at 1:13 PM | marketbeat.comAbbott Declares 406th Consecutive Quarterly DividendJune 13 at 11:34 AM | prnewswire.comCCM Investment Advisers LLC Sells 3,894 Shares of Abbott Laboratories (NYSE:ABT)CCM Investment Advisers LLC lessened its position in Abbott Laboratories (NYSE:ABT - Free Report) by 3.4% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 111,948 shares of the healthcare product maker's stock after selling 3,894 shares during the period. AJune 13 at 8:42 AM | marketbeat.comSmithbridge Asset Management Inc. DE Makes New $5.35 Million Investment in Abbott Laboratories (NYSE:ABT)Smithbridge Asset Management Inc. DE acquired a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 40,314 shares of the healthcare product makJune 13 at 7:34 AM | marketbeat.comVerity & Verity LLC Cuts Position in Abbott Laboratories (NYSE:ABT)Verity & Verity LLC decreased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 3.5% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 58,626 shares of the healthcare product maker's stock after selling 2,101 shares during the period. VerityJune 13 at 7:03 AM | marketbeat.com5 Dividend Kings Are Delivering Massive Total Returns of Up to 34% This YearJune 13 at 6:43 AM | 247wallst.comRockland Trust Co. Sells 9,548 Shares of Abbott Laboratories (NYSE:ABT)Rockland Trust Co. decreased its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 9.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 88,712 shares of the healthcare product maker's stock after selling 9,548 shares duringJune 13 at 5:55 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Abbott Laboratories (NYSE:ABT - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the nineteen analysts that are covering the company, Marketbeat reports. Four investment analysts have rated the stock with a hold rating, fourteen have given a buy rating andJune 13 at 2:40 AM | marketbeat.comStocks To Watch: Abbott Laboratories Sees RS Rating Rise To 82June 12, 2025 | msn.comCompagnie Lombard Odier SCmA Invests $100.09 Million in Abbott Laboratories (NYSE:ABT)Compagnie Lombard Odier SCmA acquired a new position in Abbott Laboratories (NYSE:ABT - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 754,559 shares of the healthcare product maker's stJune 12, 2025 | marketbeat.comUnion Bancaire Privee UBP SA Sells 13,289 Shares of Abbott Laboratories (NYSE:ABT)Union Bancaire Privee UBP SA trimmed its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 5.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 250,622 shares of the healthcare produJune 12, 2025 | marketbeat.comFerguson Wellman Capital Management Inc. Acquires 8,221 Shares of Abbott Laboratories (NYSE:ABT)Ferguson Wellman Capital Management Inc. increased its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 3.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 236,650 shares of the healthcare product makerJune 12, 2025 | marketbeat.comFifth Third Bancorp Has $169.83 Million Stake in Abbott Laboratories (NYSE:ABT)Fifth Third Bancorp reduced its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 1.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,280,278 shares of the healthcare product maker's stock after selling 1June 12, 2025 | marketbeat.comSimon Quick Advisors LLC Raises Position in Abbott Laboratories (NYSE:ABT)Simon Quick Advisors LLC increased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 20.8% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 24,231 shares of the healthcare product maker's stock after buying an additionalJune 12, 2025 | marketbeat.comRedhawk Wealth Advisors Inc. Purchases Shares of 2,236 Abbott Laboratories (NYSE:ABT)Redhawk Wealth Advisors Inc. acquired a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 2,236 shares of the healthcare product maker's stJune 12, 2025 | marketbeat.comIntegrated Advisors Network LLC Raises Stock Holdings in Abbott Laboratories (NYSE:ABT)Integrated Advisors Network LLC lifted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 30.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,003 shares of the healthcare product maker's stock after buying an additioJune 12, 2025 | marketbeat.comAbbott is deploying Texas National Guard to anti-Trump protests this weekendJune 12, 2025 | msn.com‘Abbott Elementary’ Scene-Stealer Janelle James on Ava’s Transformative Season 4June 12, 2025 | msn.comWill Abbott sign THC ban? He ponders as $8 billion industry waitsJune 12, 2025 | dallasnews.comGov. Greg Abbott sends Texas National Guard to sites of planned immigration protestsJune 12, 2025 | msn.comAbbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes SolutionsJune 11, 2025 | finance.yahoo.comMagnolia Private Wealth LLC Makes New Investment in Abbott Laboratories (NYSE:ABT)Magnolia Private Wealth LLC acquired a new stake in Abbott Laboratories (NYSE:ABT - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 1,960 shares of the healthcare product maker's stock, valued at approxiJune 11, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by InTrack Investment Management IncInTrack Investment Management Inc decreased its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 84.2% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,997 shares of the healthcare product maker's stock after selling 10,660 shares durJune 11, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Acquired by USA Financial FormulasUSA Financial Formulas lifted its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 191.9% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 11,251 shares of the healthcare product maker's stock after acquiring an addJune 11, 2025 | marketbeat.comStrategic Equity Management Buys New Position in Abbott Laboratories (NYSE:ABT)Strategic Equity Management bought a new stake in Abbott Laboratories (NYSE:ABT - Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 2,306 shares of the healthcare product maker's stock, valued at approximately $306,000.June 11, 2025 | marketbeat.comCX Institutional Purchases 50,529 Shares of Abbott Laboratories (NYSE:ABT)CX Institutional grew its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 354.8% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 64,772 shares of the healthcare product maker's stock after acquiring an additional 50,529June 11, 2025 | marketbeat.comAssenagon Asset Management S.A. Acquires 128,438 Shares of Abbott Laboratories (NYSE:ABT)Assenagon Asset Management S.A. lifted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 7.3% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,875,990 shares of the healthcare product maker's stock after purchaJune 11, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by MV Capital Management Inc.MV Capital Management Inc. lessened its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 0.8% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 282,380 shares of the healthcare product maker's stock after selJune 11, 2025 | marketbeat.com Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address ABT Media Mentions By Week ABT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABT News Sentiment▼1.140.90▲Average Medical News Sentiment ABT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABT Articles This Week▼6635▲ABT Articles Average Week Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ISRG News BSX News SYK News MDT News BDX News EW News IDXX News RMD News DXCM News STE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABT) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
